CorVel Co. (NASDAQ:CRVL – Get Free Report) VP Jennifer Yoss sold 1,214 shares of CorVel stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $300.88, for a total value of $365,268.32. Following the completion of the sale, the vice president now directly owns 680 shares of the company’s stock, valued at approximately $204,598.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
CorVel Stock Performance
Shares of CRVL stock traded down $10.82 during mid-day trading on Monday, hitting $290.39. 34,127 shares of the stock traded hands, compared to its average volume of 37,868. CorVel Co. has a twelve month low of $187.92 and a twelve month high of $321.46. The firm has a market cap of $4.98 billion, a price-to-earnings ratio of 68.46 and a beta of 1.08. The company’s 50-day simple moving average is $263.01 and its 200-day simple moving average is $252.06.
CorVel (NASDAQ:CRVL – Get Free Report) last posted its earnings results on Tuesday, July 30th. The business services provider reported $1.25 EPS for the quarter. CorVel had a net margin of 9.55% and a return on equity of 33.26%. The firm had revenue of $211.72 million for the quarter.
Institutional Inflows and Outflows
Wall Street Analysts Forecast Growth
Separately, StockNews.com downgraded CorVel from a “buy” rating to a “hold” rating in a report on Tuesday, June 25th.
Check Out Our Latest Stock Analysis on CRVL
CorVel Company Profile
CorVel Corporation provides workers' compensation, auto, liability, and health solutions for employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs.
Recommended Stories
- Five stocks we like better than CorVel
- Top Biotech Stocks: Exploring Innovation Opportunities
- From Tokyo to Wall Street: Japan’s Market Impact on U.S. Stocks
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Arm Holdings: Does the 42% Drop Signal an AI Buying Opportunity?
- What Are Dividend Contenders? Investing in Dividend Contenders
- Texas Roadhouse Stampedes On EPS Beat as Comp Sales Surge 9.3%
Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.